Rapilif 8 Tablet
By Rapilif
Rx
15 Tablet in a Strip

Composition
Silodosin(8mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
April, 2026

liver
When using Rapilif 8 Tablet, it is important to be cautious if you have severe liver disease. Patients with liver conditions may require a dose adjustment when taking Rapilif 8 Tablet, so it is crucial to consult your doctor before use. There is limited information available on the specific use of Rapilif 8 Tablet in patients with liver issues.

kidney
When using Rapilif 8 Tablet, be cautious if you have kidney disease. Your doctor may need to adjust the dosage. Avoid using this tablet if you have severe kidney disease. Consult your doctor for guidance.

alcohol
When taking Rapilif 8 Tablet, be cautious as it can increase drowsiness if consumed with alcohol.

driving
When taking Rapilif 8 Tablet, be cautious while driving as it can lead to dizziness or weakness from low blood pressure. Avoid driving if you experience these symptoms.

pregnancy
Rapilif 8 Tablet is generally safe to use during pregnancy. Animal studies show minimal adverse effects on the developing baby, but human studies are limited. It is advisable to consult a doctor before using Rapilif 8 Tablet during pregnancy.

breastfeeding
It is better to consult your doctor before using Rapilif 8 Tablet during breastfeeding. Silodosin is not recommended for use in women.
Habit Forming | No |
Chemical Class | Indolecarboxamides Derivatives |
Therapeutic Class | UROLOGY |
Action Class | Uroselective adrenergic receptor(α1a) antagonist |
₹499.6
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024